News

Nearly two decades of research and innovation are allowing us to revolutionize brain health and be recognized for it.

Learn more about our announcements and newsworthy achievements as we continue to build the world’s first precision neurology platform.

Press Releases

Altoida Announces Upcoming Poster Presentations at AD/PD 2023

Renewed Hope for Alzheimer’s Patients and Their Families

Altoida Celebrates Historic Day for Patients with Alzheimer’s Disease

Altoida Announces Upcoming Poster Presentations at AD/PD 2023

Altoida to Present at Upcoming Industry Conferences

Altoida Celebrates Historic Day for Patients with Alzheimer’s Disease

Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

Mission Based Media Launches Alzheimer's Podcast, the Newest Podcast Miniseries on Health Unmuted™

Altoida Appoints Neuroscience Pioneer Dr. Antontella Santuccione Chadha as Chief Medical Officer

Altoida Announces Partnership with Click Therapeutics to Power Clinical Trials with Digital Cognitive Assessment

Altoida Partners With GN Group to Research and Develop New Cognitive Assessment Technology to Detect Mild Cognitive Impairment

Altoida Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

Altoida and Ionian University Investigate Breakthrough Software Device for Parkinson's Disease Diagnosis

Altoida Launches 5-Year Multi-Center Alzheimer’s Study with Eisai and Ionian University

Altoida Receives Investment from Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator to Advance Precision Neurology

Altoida Awarded FDA Breakthrough Designation for Development of World’s First Precision Neurology Device for Prediction of Alzheimer's Disease

Altoida Named to the 2021 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups

Altoida Secures Funding and Research Partnership with Eisai Innovation to Accelerate Work Towards Predictive Dementia Diagnostics

Altoida Inc. Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases

Altoida Raises $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality

Media

Altoida's Alzheimer's-predicting smartphone app snags FDA breakthrough status

EIT Award winner Altoida offers free remote brain health checks during COVID-19 pandemic

Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum

Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases